Jun 24, 2026
By Transpire Insight
The global hemostats market is experiencing significant growth due to the increasing number of surgical procedures, rising prevalence of chronic diseases, growing geriatric population, and advancements in surgical technologies. Hemostatic agents are widely used to control bleeding during surgical procedures and trauma management, improving patient outcomes and reducing procedure-related complications.
The hemostats market is led by major companies such as Johnson & Johnson (Ethicon), Baxter International Inc., Becton, Dickinson and Company, Pfizer Inc., Integra LifeSciences Holdings Corporation, Stryker Corporation, Medtronic plc, CryoLife, Inc., B. Braun SE, and Teleflex Incorporated, which drive innovation in surgical bleeding control, advanced hemostatic agents, and patient care solutions worldwide.
Below is the blog that provides the list of Top 25 companies in the Hemostats Market
globally. It gives an insight into the Hemostats Market for manufacturers, investors, purchasers, and research analysts for better understanding of the market dynamics in 2026.
Johnson & Johnson, through its Ethicon division, is a global leader in surgical technologies, wound closure products, and hemostatic solutions. The company offers a comprehensive portfolio of advanced hemostatic agents and surgical products designed to improve bleeding control, surgical efficiency, and patient outcomes across a wide range of procedures.
Founded: 1886 | Headquarters: New Brunswick
Why It Ranks:
Johnson & Johnson ranks as a leading player in the hemostats market due to its extensive surgical product portfolio, strong global distribution network, continuous innovation, and well-established Ethicon brand in operating rooms worldwide.
Regional Dominance:
The company maintains a dominant presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East, serving hospitals, surgical centers, and healthcare providers globally.
Product Line:
Ethicon offers SURGICEL® absorbable hemostats, EVARREST® fibrin sealant patches, surgical sutures, wound closure products, stapling devices, energy-based surgical instruments, and advanced biosurgery solutions.
Recent Development:
The company has continued investing in advanced biosurgery technologies, expanding its hemostatic and tissue management portfolio, and developing innovative surgical solutions aimed at improving procedural outcomes and reducing healthcare costs.
Baxter International Inc. is a global healthcare company specializing in medical products, pharmaceuticals, and advanced surgical care solutions. The company is a major participant in the hemostats market, offering a broad portfolio of bleeding control products used across cardiovascular, orthopedic, neurological, and general surgical procedures.
Founded: 1931 | Headquarters: Deerfield
Why It Ranks:
Baxter ranks among the leading hemostats market players due to its strong biosurgery portfolio, extensive global presence, continuous product innovation, and established relationships with hospitals and surgical centers worldwide.
Regional Dominance:
The company has a significant presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, serving healthcare providers through a broad distribution network.
Product Line:
Baxter offers FLOSEAL® Hemostatic Matrix, TISSEEL® Fibrin Sealant, RECOTHROM® Thrombin, VERITAS® Collagen Matrix, surgical sealants, and advanced biosurgery products for bleeding management and tissue sealing.
Recent Development:
The company has continued expanding its advanced surgery portfolio through investments in biosurgery innovation, product enhancements, and strategic initiatives aimed at improving surgical efficiency, patient safety, and clinical outcomes.
Becton, Dickinson and Company (BD) is a global medical technology company that develops and manufactures medical devices, diagnostic systems, and healthcare solutions. Through its surgery and interventional business segments, the company provides products that support bleeding management, tissue repair, and surgical efficiency across a wide range of clinical settings.
Founded: 1897 | Headquarters: Franklin Lakes
Why It Ranks:
BD ranks among the leading companies in the hemostats market due to its strong medical technology portfolio, extensive global distribution network, continuous innovation in surgical products, and broad presence across hospitals and healthcare facilities worldwide.
Regional Dominance:
The company maintains a strong presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, serving healthcare providers through an extensive commercial and distribution infrastructure.
Product Line:
BD offers hemostatic products, surgical sealants, biosurgery solutions, hernia repair products, tissue reinforcement materials, surgical instruments, and advanced medical devices used in operating rooms and interventional procedures.
Recent Development:
The company has continued investing in surgical innovation, portfolio expansion, and healthcare technology advancements while strengthening its position in advanced surgery and bleeding management solutions through product development and strategic growth initiatives.
Download Sample Copy of Hemostats Market: https://www.transpireinsight.com/request-sample/3271
Pfizer Inc. is one of the world's largest biopharmaceutical companies, engaged in the discovery, development, manufacturing, and commercialization of medicines and healthcare products. In the hemostats market, the company participates through thrombin-based products and biologic solutions used for surgical bleeding control and tissue management.
Founded: 1849 | Headquarters: New York City
Why It Ranks:
Pfizer ranks among notable participants in the hemostats market due to its strong biologics expertise, extensive healthcare presence, global distribution capabilities, and established portfolio of surgical and specialty care products.
Regional Dominance:
The company has a significant presence across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa, serving hospitals, healthcare systems, and specialty care providers worldwide.
Product Line:
Pfizer offers thrombin-based hemostatic products, biologic surgical agents, specialty pharmaceuticals, vaccines, oncology therapies, inflammation treatments, and hospital care products.
Recent Development:
The company has continued investing in biologics research, advanced therapeutic development, and strategic partnerships while strengthening its specialty care portfolio and expanding access to innovative healthcare solutions globally.
Integra LifeSciences Holdings Corporation is a global medical technology company specializing in neurosurgery, regenerative technologies, wound care, and surgical solutions. The company is a prominent player in the hemostats market, offering advanced products designed to control bleeding and support tissue repair during surgical procedures.
Founded: 1989 | Headquarters: Princeton
Why It Ranks:
Integra LifeSciences ranks among the leading hemostats market participants due to its strong biosurgery portfolio, specialized expertise in surgical bleeding management, innovative regenerative technologies, and established presence in hospitals worldwide.
Regional Dominance:
The company maintains a strong presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East, serving healthcare providers in neurosurgery, orthopedics, general surgery, and wound management.
Product Line:
Integra offers SURGIFOAM® absorbable gelatin sponge, SURGIFLO® hemostatic matrix, collagen-based hemostats, dural repair products, wound care solutions, regenerative tissue technologies, and surgical instruments.
Recent Development:
The company has continued investing in biosurgery innovation, expanding its regenerative medicine portfolio, and enhancing its advanced hemostatic product offerings to improve surgical outcomes and support growing demand for effective bleeding management solutions.
Stryker Corporation is a leading global medical technology company that develops and manufactures medical devices, surgical equipment, and healthcare solutions. The company serves hospitals, surgical centers, and healthcare professionals with products used in orthopedics, neurotechnology, trauma care, and advanced surgical procedures, including bleeding management applications.
Founded: 1941 | Headquarters: Kalamazoo
Why It Ranks:
Stryker ranks among the leading hemostats market participants due to its strong surgical technology portfolio, extensive global healthcare presence, continuous product innovation, and broad customer base across multiple surgical specialties.
Regional Dominance:
The company has a significant presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, serving healthcare providers through an extensive distribution and service network.
Product Line:
Stryker offers hemostatic products, surgical instruments, powered surgical systems, orthopedic implants, neurotechnology devices, trauma care products, endoscopy equipment, and advanced operating room solutions.
Recent Development:
The company has continued investing in surgical innovation, digital healthcare technologies, and portfolio expansion through product development and strategic acquisitions, strengthening its position in advanced surgical care and bleeding management solutions.
Medtronic plc is one of the world's largest medical technology companies, developing and manufacturing medical devices, surgical technologies, and healthcare solutions across multiple therapeutic areas. The company plays an important role in the hemostats market through its advanced surgical products and bleeding management solutions used in minimally invasive and open surgical procedures.
Founded: 1949 | Headquarters: Dublin
Why It Ranks:
Medtronic ranks among the leading hemostats market participants due to its extensive surgical portfolio, strong global presence, continuous innovation in medical technologies, and broad adoption of its products in hospitals and surgical centers worldwide.
Regional Dominance:
The company maintains a dominant presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, serving healthcare providers through a comprehensive global distribution network.
Product Line:
Medtronic offers hemostatic products, surgical sealants, electrosurgical instruments, advanced energy devices, minimally invasive surgical systems, wound closure solutions, and specialty surgical technologies.
Recent Development:
The company has continued expanding its surgical technologies portfolio through investments in minimally invasive procedures, robotic-assisted surgery, and advanced tissue management solutions, strengthening its position in the global surgical care market.
CryoLife, Inc. (now operating as part of Artivion, Inc.) is a medical technology company specializing in cardiac and vascular surgery products. The company is recognized for its expertise in surgical sealants, biologic materials, and technologies used to support bleeding control and tissue repair during complex surgical procedures.
Founded: 1984 | Headquarters: Kennesaw
Why It Ranks:
CryoLife ranks among notable participants in the hemostats market due to its specialized portfolio of surgical sealants, biologic implants, and tissue preservation technologies used in cardiovascular and vascular surgeries.
Regional Dominance:
The company has a strong presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East, serving hospitals and surgical centers specializing in cardiac and vascular procedures.
Product Line:
CryoLife offers BioGlue® surgical adhesive, cardiac and vascular surgical sealants, biologic implants, preserved human tissues, aortic repair products, and specialty surgical solutions for bleeding control and tissue reinforcement.
Recent Development:
Following its rebranding to Artivion, the company has continued expanding its portfolio of cardiac and vascular surgery technologies through product innovation, strategic acquisitions, and investments in advanced tissue preservation and surgical repair solutions.
Braun SE is a global healthcare and medical technology company that develops pharmaceutical products, infusion therapies, surgical instruments, and advanced wound management solutions. The company is a significant participant in the hemostats market, offering products that support bleeding control, tissue management, and surgical efficiency across various medical specialties.
Founded: 1839 | Headquarters: Melsungen
Why It Ranks:
B. Braun ranks among the leading hemostats market players due to its extensive healthcare portfolio, strong global presence, long-standing industry expertise, and continuous investment in surgical and wound care innovations.
Regional Dominance:
The company maintains a strong presence across Europe, North America, Asia-Pacific, Latin America, the Middle East, and Africa, serving hospitals, surgical centers, and healthcare providers worldwide.
Product Line:
B. Braun offers hemostatic agents, surgical sealants, wound care products, sutures, infusion therapy systems, surgical instruments, and advanced healthcare solutions for operating rooms and clinical settings.
Recent Development:
The company has continued investing in surgical innovation, digital healthcare technologies, and sustainable healthcare solutions while expanding its portfolio of advanced wound management and bleeding control products to improve patient outcomes and procedural efficiency.
Teleflex Incorporated is a global medical technology company that develops and manufactures specialty medical devices used in critical care, surgery, urology, vascular access, and interventional procedures. The company participates in the hemostats market through products designed to support bleeding control, tissue management, and surgical efficiency.
Founded: 1943 | Headquarters: Wayne
Why It Ranks:
Teleflex ranks among the leading hemostats market participants due to its strong portfolio of surgical and interventional products, broad global distribution network, continuous innovation, and established presence in hospitals and ambulatory surgical centers worldwide.
Regional Dominance:
The company maintains a significant presence across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, serving healthcare providers through a comprehensive international sales and distribution network.
Product Line:
Teleflex offers hemostatic products, surgical clips, ligation devices, vascular access systems, critical care products, interventional devices, respiratory care products, and specialty surgical technologies.
Recent Development:
The company has continued expanding its surgical and interventional portfolio through product innovation, strategic acquisitions, and investments in advanced medical technologies aimed at improving procedural outcomes, patient safety, and healthcare efficiency.
Complete Top 25 Rankings - Hemostats Market Companies
Future Opportunities:
|
Future Opportunity |
Impact on Market Growth |
|
Increasing surgical procedures and aging population |
Expands demand for effective bleeding control products across multiple surgical specialties. |
|
Growing adoption of minimally invasive and robotic surgeries |
Creates opportunities for advanced, easy-to-use, and rapid-action hemostatic agents. |
|
Rising healthcare investments in emerging economies |
Enhances market penetration through improved access to surgical care and advanced medical technologies. |
|
Development of biologics-based and next-generation absorbable hemostats |
Supports innovation, improves surgical outcomes, and strengthens long-term market growth. |
Conclusion
The hemostats market is expected to experience robust growth due to increasing surgical volumes, technological advancements, and rising demand for efficient bleeding management solutions. Continued innovation in absorbable, biologically active, and combination hemostatic products, coupled with expanding healthcare infrastructure in emerging regions, will drive market expansion. Companies that focus on product efficacy, surgical efficiency, and advanced healthcare solutions are likely to maintain a strong competitive position in the evolving global hemostats market.
Send us a brief description of your challenge and we'll get back to you within 24 hours.
inquiry@transpireinsight.com
APAC:+91 7666513636
Address
